- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03974438
Acupuncture as Treatment of Post-herpetic Neuralgia: A RCT A Double-blinded Randomized Clinical Trial.
Acupuncture (Dry-needling) as Treatment of Post-herpetic Neuralgia: A Double-blinded Randomized Clinical Trial.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to investigate the possible effect of SDN on PHN. The study population consists of patients with chronic pain after herpes zoster.
The study is a controlled double-blinded randomized study. The participants will be divided into two groups, group A, the intervention group, will receive SDN in the area of pain. Group B, the control group will receive a sham procedure. The procedure will take place at the out-patient clinic at Odense University Hospital. The plan is to include 40 patients (20 in each group).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Funen
-
Odense, Funen, Denmark, 5000
- Odense University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age between 50-75 years.
- Pain in the dermatomal area of the previous outbreak of HZ.
- Pain located to a dermatome originating from the thoracic or lumbar spine.
- At least six months since the outbreak.
- Understands the purpose of the study and is able to give consent.
Exclusion Criteria:
- A psychiatric illness affecting participation in the study.
- Active cancer
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention - Acupunture (SDN)
Patients allocated to the intervention arm will receive SDN to the area of skin over the spine on the level of the specific dermatome involved in their chronic pain.
|
Se arm-description.
|
SHAM_COMPARATOR: Control - Sham acupunture
Patients allocated to the control arm will receive sham-SDN to the area of skin over the spine on the level of the specific dermatome involved in their chronic pain.
The sham procedure consists of a blunted needle, that does not penetrate the skin.
|
Se arm-description.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dermal pain [LEVEL OF PAIN]
Time Frame: 1 month
|
Questionnaire.
Visual Analogue Scale (VAS).
Patients will be asked to report on their average and maximum level of pain on a scale from 0-10.
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Neuropathic pain [LEVEL OF PAIN]
Time Frame: 1 month
|
Neuropathic Pain Symptom inventory (NPSI), Questionnaire. NPSI consists of 12 items in total: 10 items investigates differential symptoms descriptors and 2 items evaluate spontaneous and paroxysmal spontaneous pain. The tool evaluates mean pain intensity in the last 24h in a verbal numeric scale from zero (no pain) to 10 (worst imaginable pain). Total pain intensity score may be calculated by the sum of the 10 descriptors. The descriptors are: Burning, Squeezing, Pressure, Electric Shocks, Stabbing, Provoked by brushing. Provoked by pressure, Evoked by cold stimulation, Pins and needles, Tingling. |
1 month
|
Quality of life [QUALITY OF LIFE/ SATISFACTION]
Time Frame: 1 month
|
Short Form 36 (SF-36), Questionnaire. Scoring the RAND 36-Item Health Survey is a two-step process. First, precoded numeric values are recoded per a scoring key. All items are scored so that a high score defines a more favorable health state. Each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Scores represent the percentage of total possible score achieved. After this, items in the same scale are averaged together to create the 8 scale scores. The eight health concepts are: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. It also includes a single item that provides an indication of perceived change in health. |
1 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- S-20190101
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Herpetic Neuralgia
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPost Herpetic NeuralgiaUnited States, Colombia, South Africa, Hong Kong, Ukraine, Bulgaria, Croatia, India, Sweden, Czechia, Denmark, Germany, Poland, Russian Federation, Serbia, Slovakia, Taiwan
-
Bial - Portela C S.A.Terminated
-
DepomedCompletedPost Herpetic NeuralgiaUnited States
-
Grünenthal GmbHCompletedPost Herpetic Neuralgia
-
Novartis PharmaceuticalsTerminatedPost-herpetic NeuralgiaAustralia, Taiwan, Germany, France, Portugal, Czechia, United Kingdom, Hungary, Spain, Slovakia, Japan, Canada, Denmark, Norway, Austria, Belgium, Poland, Italy, Korea, Republic of
-
Convergence PharmaceuticalsCompletedPost-herpetic NeuralgiaSouth Africa
-
University of Sao PauloCompletedPost-herpetic Neuralgia
-
NeurAxon Inc.CompletedPost Herpetic NeuralgiaUnited States, Canada
-
Bristol-Myers SquibbCompleted
-
EpiCept CorporationCompletedNeuropathy | Nerve Pain | Post Herpetic Neuralgia | PHNIndia
Clinical Trials on Superficial dry needling / Acupunture
-
Ohio State UniversityRecruitingPatellofemoral Pain Syndrome | Anterior Knee Pain SyndromeUnited States
-
University of AlcalaCompletedDry Needling | Stretch | Rectus Femoris MuscleSpain
-
Cardenal Herrera UniversityCompleted
-
Youngstown State UniversityNot yet recruiting
-
Army-Baylor University Doctoral Program in Physical...Brooke Army Medical CenterCompletedChronic Pain | Shoulder Pain | Musculoskeletal InjuryUnited States
-
Brigham Young UniversityTerminatedMyofascial Pain Syndrome | Myofascial Trigger Point PainUnited States
-
Youngstown State UniversityRecruiting
-
Universidad de ZaragozaCompleted
-
Institute of Technology, CarlowCompleted
-
Universidad de ZaragozaUnknownHip OsteoarthritisSpain